Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -13.80%1.14B | -11.60%282M | -13.17%290M | -17.24%288M | -12.89%277M | -6.25%1.32B | -7.80%319M | -2.91%334M | -1.14%348M | -12.88%318M |
Cost of revenue | -3.02%193M | -4.17%46M | -5.56%51M | -4.08%47M | 2.08%49M | 12.43%199M | 2.13%48M | 20.00%54M | 16.67%49M | 11.63%48M |
Gross profit | -15.73%943M | -12.59%236M | -14.64%239M | -19.40%241M | -15.93%227M | -8.95%1.12B | -9.70%270M | -6.04%280M | -3.55%299M | -16.15%270M |
Operating expense | -19.94%522M | 13.70%166M | -30.59%118M | -30.52%107M | -28.02%131M | -10.68%652M | -21.08%146M | -7.61%170M | -21.83%154M | 10.98%182M |
Operating profit | -9.85%421M | -43.55%70M | 10.00%121M | -7.59%134M | 9.09%96M | -6.41%467M | 8.77%124M | -3.51%110M | 28.32%145M | -44.30%88M |
Net non-operating interest income (expenses) | 0.72%281M | 0.00%70M | -1.39%71M | 0.00%70M | 4.48%70M | 11.60%279M | 6.06%70M | 14.29%72M | 14.75%70M | 11.67%67M |
Non-operating interest income | 0.72%281M | 0.00%70M | -1.39%71M | 0.00%70M | 4.48%70M | 11.60%279M | 6.06%70M | 14.29%72M | 14.75%70M | 11.67%67M |
Net investment income | 828.57%65M | -33.33%14M | -39.66%35M | 7M | 21M | 58M | ||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 9M | 0 | ||||||||
Less:Other special charges | ---9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -77.06%25M | -129.63%-16M | -20.69%23M | -20.00%12M | -45.45%6M | |||||
Income before tax | 0.00%779M | 3.78%192M | 31.50%167M | -11.74%218M | -8.18%202M | -7.81%779M | -20.60%185M | -33.85%127M | 29.32%247M | -3.93%220M |
Income tax | -11.87%193M | 450.00%35M | -26.15%48M | -30.12%58M | -35.80%52M | 73.81%219M | 91.74%-10M | -15.58%65M | 10.67%83M | -14.74%81M |
Net income | 4.83%586M | -18.97%158M | 95.08%119M | -2.44%160M | 7.19%149M | -22.25%559M | -45.07%195M | -46.96%61M | 41.38%164M | 4.51%139M |
Net income continuous operations | 4.64%586M | -19.49%157M | 91.94%119M | -2.44%160M | 7.91%150M | -22.11%560M | -44.92%195M | -46.09%62M | 41.38%164M | 3.73%139M |
Noncontrolling interests | -15.52%49M | -30.77%9M | -6.67%14M | -17.65%14M | -7.69%12M | -3.33%58M | -13.33%13M | 0.00%15M | 21.43%17M | -18.75%13M |
Net income attributable to the company | 6.99%536M | -19.13%148M | 135.56%106M | -2.03%145M | 9.60%137M | -23.86%501M | -46.18%183M | -54.55%45M | 45.10%148M | 6.84%125M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 6.99%536M | -19.13%148M | 135.56%106M | -2.03%145M | 9.60%137M | -23.86%501M | -46.18%183M | -54.55%45M | 45.10%148M | 6.84%125M |
Gross dividend payment | ||||||||||
Basic earnings per share | 6.86%13.4 | -19.04%3.7 | 131.58%2.64 | -1.63%3.63 | 9.24%3.43 | -23.82%12.54 | -46.24%4.57 | -54.03%1.14 | 44.71%3.69 | 7.17%3.14 |
Diluted earnings per share | 6.86%13.4 | -19.07%3.6987 | 134.75%2.64 | -1.80%3.6237 | 9.24%3.43 | -23.82%12.54 | -46.22%4.57 | -54.55%1.1246 | 44.76%3.69 | 7.17%3.14 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |